TRIM50 overexpression inhibited pancreatic cancer cell proliferation, migration, and invasion in vitro and suppressed pancreatic cancer growth and distant metastasis in vivo, while TRIM50 knockdown had the opposite effects in vitro. Here, TRIM50 is linked to familial pancreatic carcinoma.